Clarisse Audigier-Valette

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome

Lisa Derosa, Valerio Iebba, Carolina Alves Costa Silva et al. · Cell · 2024 · 164 citations · Full text

Life Sciences, Immunology, Oncology +17

Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial.

Arnaud Scherpereel, Julien Mazieres, Laurent Greillier et al. · Journal of Clinical Oncology · 2017 · 51 citations

Medicine, Oncology, Pharmacology +16

Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial.

Arnaud Scherpereel, Julien Mazieres, Laurent Greillier et al. · Journal of Clinical Oncology · 2017 · 23 citations

Medicine, Oncology, Pharmacology +16

Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers

Anne Mc Leer, Matthieu Foll, Marie Brevet et al. · Lung Cancer · 2022 · 19 citations

Medicine, Genetics, Oncology +15

Surrogate markers of intestinal dysfunction associated with survival in advanced cancers

Roxanne Birebent, Damien Drubay, Carolina Alves Costa Silva et al. · OncoImmunology · 2025 · 14 citations · Full text

Medicine, Immunology, Oncology +17